Hepion Pharmaceuticals, Inc. (HEPA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 578.58K | -332.77K | -445.96K | -1.38M | -1.12M | -1.15M | -2.52M | -10.93M | -3.62M | -9M | -11.24M | -12.44M | -8.21M | -4.8M | -12.53M | -7.5M | -10.13M | -7.38M | -11.32M | -5.17M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 151.78% | 71.14% | 82.29% | 87.42% | 69.1% | 87.19% | 77.59% | 12.12% | 55.97% | -87.63% | 10.36% | -65.82% | 18.9% | 35.01% | -10.7% | -45.08% | -37.83% | -63.13% | -194.07% | -66.16% |
| Net Income | 0 | -656.88K | -472.51K | -1.04M | -6.11M | -1.55M | -4.87M | -3.93M | -2.85M | -11.06M | -10.53M | -14.08M | -13.26M | -6.81M | -8.55M | -19.91M | -6.93M | -9.72M | -9.27M | -7.67M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 474.57K | 0 | 30.76K | 12.27K | 18.5K | 18.33K | 18.04K | 18.48K | 17.73K | 18.53K | 22.73K | 23.41K | 23.11K | 21.41K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 20.78K | 28.63K | 28.63K | 28.63K | 705.77K | 150.32K | 318.91K | -1.06M | 1.93M | 231.94K | 616.84K | 162.51K | 1.54M | 847.52K | 1.47M | 1.39M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -800.64K | 34.62K | -135.37K | -295.33K | 4.8M | 321.62K | -396.17K | -4.53M | 636.39K | 3.84M | -140K | -88.43K | 48.43K | 315.95K | 80K | 9.44M | -324.99K | 892.72K | 749.99K | 810.01K |
| Working Capital Changes | 1.38M | 289.49K | 161.91K | -37.46K | 167.2K | 44.34K | 2.24M | -2.5M | -2.14M | -1.94M | -906.71K | 2.77M | 3.05M | 1.45M | -4.7M | 2.79M | -4.44M | 576.15K | -4.3M | 271.1K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 240.25K | 112.22K | 0 | 0 | 165.86K | -248.37K | 0 | 0 | 0 | 0 | -1.38M | 2.25M | 566.62K | 0 | -5.89M | 0 | 0 | 0 | -1.03M | 0 |
| Cash from Investing | 0 | 0 | 0 | -132.12K | 0 | 0 | -600K | 0 | 0 | -348 | 2.58K | -16.54K | 0 | -16.34K | 0 | 2.27K | 0 | 1 | -36.49K | -11.81K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -348 | 2.58K | -16.54K | 0 | -16.34K | 0 | 0 | 0 | 1 | -36.49K | -11.81K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -132.12K | 0 | 0 | -600K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.27K | 0 | 0 | 0 | 0 |
| Cash from Financing | 195.93K | -160.24K | -157.35K | -154.52K | 5.3M | 0 | 2.5M | 0 | 1.85M | 4.49M | 0 | 0 | 0 | -3.14M | 0 | 0 | -2M | 0 | 0 | -176.59K |
| Debt Issued (Net) | -54.07K | -160.24K | 0 | -154.52K | -2.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 9M | 0 | 0 | 0 | 1.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 250K | 0 | -157.35K | 0 | -802.6K | 0 | 2.5M | 0 | 0 | 4.49M | 0 | 0 | 0 | -3.14M | 0 | 0 | -2M | 0 | 0 | -176.59K |
| Net Change in Cash | 774.52K | -493.02K | -603.32K | -1.66M | 4.18M | -1.09M | -617.94K | -10.99M | -1.68M | -4.5M | -11.24M | -12.47M | -8.2M | -7.96M | -12.56M | -7.52M | -12.13M | -7.38M | -11.36M | -5.36M |
| Free Cash Flow | 578.58K | -332.77K | -445.96K | -1.38M | -1.12M | -1.15M | -2.52M | -10.93M | -3.62M | -9M | -11.23M | -12.45M | -8.21M | -4.81M | -12.53M | -7.5M | -10.13M | -7.38M | -11.36M | -5.18M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 151.78% | 71.14% | 82.29% | 87.42% | 69.1% | 87.19% | 77.59% | 12.24% | 55.97% | -87.01% | 10.38% | -66.04% | 18.9% | 34.79% | -10.34% | -44.75% | -36.31% | -60.42% | -195.02% | -65.93% |
| FCF per Share | 0.05 | -0.04 | -0.04 | -0.12 | -0.39 | -8.28 | -18.74 | -94.23 | -35.65 | -98.61 | -146.34 | -162.72 | -107.76 | -63.15 | -164.43 | -98.39 | -132.88 | -96.85 | -149.03 | -67.98 |
| FCF Conversion (FCF/Net Income) | -0.71x | 0.51x | 0.94x | 1.32x | 0.18x | 0.75x | 0.52x | 2.78x | 1.27x | 0.81x | 1.07x | 0.88x | 0.62x | 0.70x | 1.47x | 0.38x | 1.46x | 0.76x | 1.22x | 0.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 941 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |